Back

Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals

Vergara, C.; Ni, Z.; Zhong, J.; McKean, D.; Connelly, K. E.; Antwi, S. O.; Arslan, A. A.; Bracci, P. M.; Du, M.; Gallinger, S.; Genkinger, J.; Haiman, C. A.; Hassan, M.; Hung, R. J.; Huff, C.; Kooperberg, C.; Kastrinos, F.; LeMarchand, L.; Lee, W.; Lynch, S. M.; Moore, S. C.; Oberg, A. L.; Park, M. A.; Permuth, J. B.; Risch, H. A.; Scheet, P.; Schwartz, A.; Shu, X.-O.; Stolzenberg-Solomon, R. Z.; Wolpin, B. M.; Zheng, W.; Albanes, D.; Andreotti, G.; Bamlet, W. R.; Beane-Freeman, L.; Berndt, S. I.; Brennan, P.; Buring, J. E.; Cabrera-Castro, N.; Campa, D.; Canzian, F.; Chanock, S. J.; Chen, Y.;

2026-04-22 genetic and genomic medicine
10.64898/2026.04.21.26351329 medRxiv
Show abstract

Pancreatic cancer disproportionately affects Black individuals in the United States, but they have limited representation in genetic studies of pancreatic ductal adenocarcinoma (PDAC). To address this gap, we performed admixture mapping and genome-wide association analysis (GWAS) in genetically inferred African ancestry individuals (1,030 cases and 889 controls). Admixture mapping identified three regions with a significantly higher proportion of African ancestry in cases compared to controls (5q33.3, 10p1, 22q12.3). GWAS identified a genome-wide significant association at 5p15.33 (CLPTM1L, rs383009:T>C, T Allele Frequency=0.51, OR:1.45, P value=1.24x10-8), a locus previously associated with PDAC. Known loci at 5p15.33, 7q32.3, 8q24.21 and 7q25.1 also replicated (P value <0.01). Multi-ancestral fine-mapping identified two potential causal SNPs (rs3830069 and rs2735940) at 5p15.33. Collectively these findings identified novel PDAC risk loci and expanded our understanding of this deadly cancer in underrepresented populations, emphasizing the multifactorial nature of PDAC risk including inherited genetic and non-genetic factors. Statement of SignificanceTo understand how genetic variation contributes to PDAC risk in Black people in North American, we studied individuals of genetically-inferred African ancestry. We identified novel risk loci and differences in the contribution of known loci. This demonstrates that ancestry-informed genetic analyses improve our understanding of PDAC risk and enhances discovery.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Genetics in Medicine
69 papers in training set
Top 0.2%
9.1%
2
Gut
36 papers in training set
Top 0.1%
8.4%
3
Cancer Epidemiology, Biomarkers & Prevention
17 papers in training set
Top 0.1%
6.8%
4
Nature Genetics
240 papers in training set
Top 1%
6.3%
5
The American Journal of Human Genetics
206 papers in training set
Top 0.8%
6.3%
6
Human Molecular Genetics
130 papers in training set
Top 0.5%
4.8%
7
Molecular Metabolism
105 papers in training set
Top 0.5%
3.6%
8
Scientific Reports
3102 papers in training set
Top 37%
3.6%
9
Genome Medicine
154 papers in training set
Top 3%
2.7%
50% of probability mass above
10
eLife
5422 papers in training set
Top 31%
2.7%
11
Nature Communications
4913 papers in training set
Top 52%
1.7%
12
JCI Insight
241 papers in training set
Top 4%
1.7%
13
Oncogene
76 papers in training set
Top 1%
1.7%
14
JNCI: Journal of the National Cancer Institute
16 papers in training set
Top 0.4%
1.5%
15
Cell Genomics
162 papers in training set
Top 4%
1.3%
16
PLOS ONE
4510 papers in training set
Top 58%
1.3%
17
Human Genetics and Genomics Advances
70 papers in training set
Top 0.4%
1.3%
18
Cancer Research Communications
46 papers in training set
Top 0.6%
1.3%
19
BMC Genomics
328 papers in training set
Top 4%
1.2%
20
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 38%
1.2%
21
npj Genomic Medicine
33 papers in training set
Top 0.7%
0.9%
22
Diabetologia
36 papers in training set
Top 0.8%
0.9%
23
Alzheimer's & Dementia
143 papers in training set
Top 2%
0.9%
24
Gastroenterology
40 papers in training set
Top 2%
0.8%
25
Journal of Clinical Investigation
164 papers in training set
Top 7%
0.7%
26
Frontiers in Genetics
197 papers in training set
Top 10%
0.7%
27
PLOS Genetics
756 papers in training set
Top 15%
0.7%
28
BMC Cancer
52 papers in training set
Top 3%
0.7%
29
Cellular and Molecular Gastroenterology and Hepatology
41 papers in training set
Top 0.6%
0.7%
30
JNCI Cancer Spectrum
10 papers in training set
Top 0.5%
0.7%